Â鶹´«Ã½

Skip to main content

Staff Profile

Dr Jeremy Palmer

Team Scientist

Publications
  • Luukkonen PK, Zhou Y, Nidhina Haridas PA, Dwivedi OP, Hyotylainen T, Ali A, Juuti A, Leivonen M, Tukiainen T, Ahonen L, Scott E, Palmer JM, Arola J, Orho-Melander M, Vikman P, Anstee QM, Olkkonen VM, Oresic M, Groop L, Yki-Jarvinen H. . Journal of Hepatology 2017, 67(1), 128-136.
  • Probert PM, Palmer JM, Alhusainy W, Amer AO, Rietjens IMCM, White SA, Jones DE, Wright MC. . Toxicology Letters 2016, 243, 98-110.
  • Dyson JK, Palmer J, Wong LL, Kendrick S, Jones DE. . In: 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016. 2016, Boston, MA: John Wiley & Sons, Inc.
  • Nichols EM, Barbour TD, Kerr H, Pappworth IY, Wong EKS, Palmer J, Sheerin NS, Herbert A, Barlow PN, Pickering MC, Marchbank KJ. . In: 15th European Meeting on Complement in Human Disease 2015. 2015, Uppsala, Sweden: Elsevier.
  • Palmer J, Liu YL, Day CP, Daly A, Anstee QM. . In: 50th Annual Meeting of the European Association for the Study of the Liver. 2015, Vienna, Austria: Elsevier.
  • Jopson L, Newton JL, Palmer J, Floudas A, Isaacs J, Qian J, Wilkinson J, Trenell M, Blamire A, Howel D, Jones DE. . BMJ Open 2015, 5(8), e007985.
  • Jopson L, Newton JL, Howel D, Palmer J, Isaacs J, Qian J, Wilkinson J, Blamire A, Floudas A, Jones DE. . In: 50th Annual meeting of the European Association for the Study of the Liver. 2015, Vienna, Austria: Elsevier.
  • Floudas A, Griffiths L, Jones D, Knight AM, Palmer JM. . In: BSI Congress 2013: Annual Congress of the British-Society-for-Immunology. 2013, Liverpool, England: Wiley-Blackwell Publishing Ltd.
  • Pells G, Ducker S, Palmer J, Newton J, Jones D, UK-PBC Consortium. . In: British Society of Gastroenterology Annual General Meeting. 2013, Glasgow, UK: BMJ Publishing Group.
  • Palmer JM, Amoaku WM, Kamali F. . Eye 2013, 27(9), 1090-1097.
  • O'Boyle G, Fox CR, Walden HR, Willet JD, Mavin ER, Hine DW, Palmer JM, Barker CE, Lamb CA, Ali S, Kirby JA. . Proceedings of the National Academy of Sciences 2012, 109(12), 4598-4603.
  • Palmer J, Patanwala I, Henderson E, Day CP, Jones DE. . In: 61st Annual Meeting of the American Association for the Study of Liver Diseases. 2010, Boston, MA: Hepatology: Wiley-Blackwell.
  • Jones DEJ, Robe A, Palmer J, Kirby JA. . In: 41st Annual Meeting of the European Association for the Study of the Liver. 2006, Vienna, Austria: ELSEVIER SCIENCE BV.
  • McHugh A, Palmer JM, Yeaman SJ, Jones DEJ. . In: Hepatology: 54th Annual Meeting of the American Association for the Study of Liver Disease. 2003, Boston, Massachusetts, USA: John Wiley & Sons, Inc.
  • Robe AJ, Palmer JM, Kirby JA, Bassendine MF, Jones DEJ. . Gut 2002, 50(s2), A116 abstract no. 428.
  • Palmer JM, Stewart S, Kirby J, Jones D. . In: Hepatology: 53rd Annual Meeting of the Association for the Study of Liver Diseases. 2002, Boston, Massachusetts, USA: John Wiley & Sons, Inc.
  • Robe A, Palmer J, Kirby J, Jones D. . In: Journal of Hepatology. 2002, Elsevier BV.
  • Palmer JM, Yeaman SJ, Jones DEJ. . In: Journal of Hepatology. 2001, Elsevier BV.
  • Jones DE, Robe AJ, Palmer JM, Kirby JA. Exploration of the immunogenicity of the primary biliary cirrhosis autoantigen pyuvate dehydrogenase complex. Hepatology 2001, 34, 730.
  • Bassendine MF, Palmer JM, Yeaman SJ, Kirby JA, Jones DEJ. Immunological aspects of chronic cholestatic liver diseases. In "FALK Workshop on Hepatobiliary Diseases: Cholestasis and Gallstones" pp 32-41 Eds. Acalovschi and Paumgartner Pub. Kluwer Academic Publishers<br>(Chapter) 2001.
  • Robe AJ, Palmer JM, Kirby JA, Jones DE. No role for autoreactive antibody in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex, the autoantigen in primary biliary cirrhosis. In: Hepatology. 2001, John Wiley & Sons, Inc.
  • Burt AD, Jones DEJ, Palmer JM, Kirby JA, Cruz DeDJ, McCaughan GW, Sedgewick JD, Yeaman SJ, Bassendine MF. Histopathology of experimental autoimmune cholangitis - a mouse model of primary biliary cirrhosis. Journal of Pathology 2000, 190, 3A-3A.
  • Palmer JM, Doshi M, Kirby JA, Yeaman SJ, Bassendine MF, Jones DEJ. . Clinical and Experimental Immunology 2000, 122(3), 423-428.
  • Robe A, Palmer JM, Yeaman SJ, Jones DEJ. The E3BP (protein X) component of pyruvate dehydrogenase complex (PDC) is not a T-cell autoantigen in primary biliary cirrhosis (PBC). In: JOURNAL OF HEPATOLOGY. 2000.
  • Jones DE, Robe AJ, Palmer JM, Yeaman SJ, Kirby JA. The role played by gender in breakdown of immune tolerance in experimental autoimmune cholangitis: A mouse model of primary biliary cirrhosis. In: HEPATOLOGY. 2000.
  • Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MA. Bacterial motif DNA as ad adjuvant for the development of autoimmunity in primary biliary cirrhosis (PBC). Gut 1999, 44, TH390.
  • Palmer JM, Jones DEJ, Quinn J, McHugh A, Yeaman SJ. . Hepatology 1999, 30(1), 21-26.
  • Palmer JM, Kirby JA, Yeaman SJ, Doshi M, Jones DE. . In: Hepatology. 1999, John Wiley & Sons, Inc.
  • Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF, Burt AD. The time-course of bile duct lesion development in experimental autoimmune cholangitis (A mouse model of primary biliary cirrhosis -PBC). In: HEPATOLOGY. 1999.
  • Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF, Burt AD. The time-course of bile duct lesion development in experimental autoimmune cholangitis (a mouse model of primary biliary cirrhosis-PBC). In: HEPATOLOGY. 1999.